EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Evolving Landscape of Immunotoxicity: Charting Mechanisms and Future Strategies for Immune Checkpoint Inhibitor Adverse Events

Anqi Lin, Keyin Zheng, Aimin Jiang, Xufeng Huang, Qi Wang, András Hajdu, Zhengrui Li, Jian Zhang, Peng Luo

Med Research · 2025-12 · 1 (3) · 322-358

DOI: 10.1002/mdr2.70019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Med Research, online erschienen am 29.07.2025. Verfasst von Anqi Lin und 8 weiteren Autor:innen. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 340 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The use of immune checkpoint inhibitors (ICIs) has significantly improved the efficacy of cancer therapy, but their associated immune‐related adverse events (irAEs) can severely compromise treatment safety. This review systematically summarizes the core mechanisms underlying irAEs, which include multi‐organ damage resulting from T‐cell dysfunction, B‐cell‐mediated autoantibody abnormalities, cytokine network dysregulation, and monocyte‐driven inflammatory cascades. Identified risk factors encompass a range of elements, including host clinical characteristics and underlying diseases, gut microbiota dysbiosis, characteristics of the treatment regimen, tumor type and its histological features, genetic factors and immunogenetic polymorphisms, pre‐existing autoimmune conditions or a history of autoimmunity, and a history of previous exposures alongside various environmental factors. The grading criteria, their clinical context and incidence rates, and clinical management strategies for irAEs affecting various organ systems are detailed herein. Future research should aim to deeply analyze the shared mechanisms and temporal dynamics between irAEs and anti‐tumor effects, develop targeted irAE prediction and monitoring systems, and optimize strategies for irAE prevention and treatment.

Zitieren

APA

Lin, A., Zheng, K., Jiang, A., Huang, X., Wang, Q., Hajdu, A., Li, Z., Zhang, J., & Luo, P. (2025). The Evolving Landscape of Immunotoxicity: Charting Mechanisms and Future Strategies for Immune Checkpoint Inhibitor Adverse Events. Med Research, 1(3), 322-358. https://doi.org/10.1002/mdr2.70019

Vancouver

Lin A, Zheng K, Jiang A, Huang X, Wang Q, Hajdu A, et al. The Evolving Landscape of Immunotoxicity: Charting Mechanisms and Future Strategies for Immune Checkpoint Inhibitor Adverse Events. Med Research. 2025;1(3):322-358. doi:10.1002/mdr2.70019

BibTeX
@article{Lin2025,
  author = {Lin, Anqi and Zheng, Keyin and Jiang, Aimin and Huang, Xufeng and Wang, Qi and Hajdu, András and Li, Zhengrui and Zhang, Jian and Luo, Peng},
  title = {The Evolving Landscape of Immunotoxicity: Charting Mechanisms and Future Strategies for Immune Checkpoint Inhibitor Adverse Events},
  journal = {Med Research},
  year = {2025},
  volume = {1},
  number = {3},
  pages = {322--358},
  doi = {10.1002/mdr2.70019}
}
Kostenlos starten →